IPDataLab Meets with CPIA President to Discuss Industry Collaboration

Today, Miao Li and Jessica Bi of IPDataLab had the privilege of meeting with Mr. Pan Guangcheng, President of the China Pharmaceutical Industry Association (CPIA), along with his colleagues. During the meeting, President Pan highly recognized IPDataLab’s business model and its vision in facilitating the global expansion of Chinese pharmaceutical companies. With the support of CPIA, we look forward to helping more Chinese pharmaceutical enterprises successfully navigate international markets, bringing their innovations to more patients.

Founded in 1988, CPIA is a leading national industry association in China and operates under the supervision of the State-owned Assets Supervision and Administration Commission of the State Council. With over 600 member organizations, including major pharmaceutical manufacturers, API manufacturers, and research institutes, CPIA plays a crucial role in shaping policies, promoting industry self-regulation, and fostering international cooperation. The association actively engages in policy advocacy, industry research, and global exchanges, supporting the sustainable growth and internationalization of China’s pharmaceutical sector.